SIZE-RELATED COLOCALIZATION OF GLYCINE AND GLUTAMATE IMMUNOREACTIVITY IN FROG AND RAT VESTIBULAR AFFERENTS

Presence and distribution of glutamate, glycine, GABA and beta-alanine in VIIIth nerves of frogs and rats were investigated with postembedding immunocytochemical methods on serial. In Scarpa's ganglion of the frog, all cell bodies were glutamate immunoreactive. About 17% semithin sections. of the cells per section were also glycine immunoreactive, but none were GABA or p-alanine immunoreactive The mean diameter of glycine-positive cell bodies (26.7 +/- 6.9 mu m; N = 130) was significantly (P < 0.0001) larger than that of glycine-negative cell bodies (15.7 +/- 5.4 mu m; N = 272). The intensity of glutamate immunostaining decreased with cell diameter, whereas the intensity of glycine immunostaining increased with cell diameter. As a result, the staining intensities for glutamate and glycine in a given cell were negatively correlated. Glycine immunoreactivity was also present in a size-related manner in distal and proximal afferent fibers. The majority of thin fibers (<4 mu m) was glycine negative, whereas most of the thick fibers (>10 mu m) were glycine positive. Glycine-positive fibers were observed in the sensory epithelia of ail end organs in the inner ear. The saccular macula and its nerve, however, contained only few glycine-immunoreactive structures. In Scarpa's ganglion of the rat, all cells were immunoreactive for glutamate, about 12% for colocalized glycine, and none for GABA or beta-alanine Glycine-positive cell bodies were significantly (P < 0.0001) larger (32.2 +/- 5.2 mu m; N = 82) than glycine-negative cell bodies (25.1 +/- 5.3 mu m; N = 274). Cell bodies in the spiral ganglion were only glutamate immunoreactive, whereas staining for glutamate, glycine, and GABA was dense in the ventral cochlear. These results demonstrate that thicker vestibular afferent fibers represent a particular subpopulation that differs from the majority of thinner afferents due to their glycine immunoreactivity. (C) 1994 Wiley-Liss, Inc.